Market Executive Summary

The global Needles revenue was US$ 7766 million in 2023 and is forecast to a readjusted size of US$ 11220 million by 2030 with a CAGR of 5.4% during the review period (2024-2030).

The needles category is a significant component of the broader Japan syringes, needles, and urinary catheters market. The total market for syringes, needles, and urinary catheters in Japan was valued at $1.41 billion in 2023, with the needles category generating the highest revenue.

The Japan medical needles market was valued at $0.8 billion in 2024 and is projected to reach $1.2 billion by 2033, showing a CAGR of 4.8% from 2026 to 2033. Disposable medical needles, a significant sub-segment, were valued at $0.7 billion in 2024 and are forecasted to reach $1.1 billion by 2033, with a CAGR of 6.5% from 2026 to 2033. 

This report focuses on global and Japan Needles market, also covers the segmentation data of other regions in regional level and county level.

Needles are a common device used for medical applications. In this report, we will study products of flowing: suture needle, hypodermic needle, etc.

Needles Market Drivers

The Needles market is primarily driven by the increasing prevalence of chronic diseases such as diabetes, cardiovascular conditions, and cancer, which require frequent administration of medications and diagnostic procedures. Additionally, the growing demand for vaccination programs to combat infectious diseases like influenza, COVID-19, and hepatitis has significantly boosted the use of Needles globally. Advances in needle technology, such as the development of ultra-thin and pain-minimizing designs, have also enhanced patient comfort and encouraged wider adoption.

Another key driver is the expansion of healthcare infrastructure in emerging economies, coupled with rising awareness about preventive healthcare. As access to medical services improves in these regions, the demand for Needles in routine procedures, such as immunizations and blood tests, is expected to increase substantially.

Needles Market Challenges

The Needles market faces challenges such as the increasing shift toward needle-free drug delivery systems, including transdermal patches and jet injectors, which aim to minimize the pain and anxiety associated with needles. These alternatives, while still emerging, pose a potential threat to the growth of the traditional Needles market.

Additionally, the risk of needlestick injuries among healthcare workers remains a significant concern, leading to stringent regulations and the need for safety-engineered needles. These advanced safety features often increase production costs, potentially impacting market profitability. Furthermore, the disposal of used needles poses environmental and public health challenges, requiring improved waste management solutions.

Needles market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Needles market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.

For Japan market, this report focuses on the Needles market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in Japan.

Global Needles Companies Covered

BD, Johnson & Johnson, B. Braun, Nipro, Terumo, Novo Nordisk, WEGO, Roche, Lifescan, Cardinal Health, Medtronic, Smiths Medical, KDL, Teleflex, Artsana, Ypsomed, Hamilton, Improve Medical, SHENGGUANG, Tiankang Medical

Global Needles Market, by Region

North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Needles Market, Segment by Type

Hypodermic Needle

Suture Needle

Lancet

Others

Global Needles Market, Segment by Application

Hospitals

Diagnostic Centers

Others

Key Trends & Drivers

Aging Population & Chronic Disease Burden

Japan’s advanced age structure, over 29% aged 65+, with 1 in 10 aged 80+, drives increased demand for needles used in surgeries, insulin injections, and cancer care. Growing chronic illnesses (e.g., diabetes, cardiovascular disease) fuel higher consumption of syringes and therapeutic needles.

Healthcare Infrastructure & Reimbursement Support

Japan’s universal healthcare and reimbursement policies facilitate widespread adoption of biologics and self-injection devices. Strong hospital and clinic networks ensure consistent needle utilization in clinical and home settings.

Regulatory Focus on Safety & Infection Control

PMDA-enforced protocols are increasing use of safety-engineered and disposable needles to minimize needlestick injuries and infections.

Technological Innovation

Rise in development of safety needles, pain-reducing (UltraTouch, RightGauge), microneedles, and steerable/flexible designs. Pen needles in diabetes care are showing high growth with an expected CAGR of around 12.9% to 2030.

Recent Developments

April 2024: BD launched UltraTouch Vacutainer, featuring RightGauge technology for gentler blood draws.

R&D and product rollouts are focusing on biodegradable, smart, and customized needles, with safety needle adoption rising.

April 2024: New tocilizumab biosimilar (Tyenne) approved for subcutaneous use in the U.S., reflecting global trends toward self-injection therapeutics.

Opportunities Ahead

Expansion in Home Healthcare & Self-Injected Therapies

The shift toward remote patient care and self-administration (insulin, biologics, autoimmune treatments) creates demand for reliable pen and unsupervised-use needles.

Microneedles & Advanced Delivery Systems

Development of microneedles for painless drug delivery and continuous monitoring is gaining traction.

Connected and “Smart” Needles

Integration with digital health platforms (e-health, telehealth) offers tracking and dose accuracy benefits.

Penetration of Rural & Specialty Markets

Emerging target segments include small clinics, ambulatory surgical centers (ASCs), and home-health setups. Technology adaptation here is slower but promising.

Eco-Friendly Manufacturing

Sustainability initiatives such as biodegradable needles and eco-conscious packaging are opening new growth avenues.

Segmented Needs: Steerable & Acupuncture Needles

Steerable needles are used in robotic and minimally invasive interventions and are growing at a healthy CAGR. Acupuncture needles are also experiencing steady growth driven by increased alternative therapy adoption.

Strategic Insight

Focus R&D on low-pain, safety-engineered, and smart-needle technologies aligned with home-use and telehealth.

Leverage digital integrations (e.g., dose tracking, connectivity) to differentiate in a competitive landscape.

Broaden reach into ASCs, rural clinics, and home-care channels, supported by eco-conscious packaging and manufacturing.

Target niche segments (steerable, acupuncture) with specialized, high-margin products.



Chapter Outline

Chapter 1: Introduces Needles definition, global sales (volume and revenue), Japan market size, Japan percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Detailed analysis of Needles companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Revenue and volume of Needles in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world. 

Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Needles sales, revenue, gross margin, and recent development, etc.

Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

Chapter 12: research findings and conclusion